Infarction, Brain Completed Phase 3 Trials for Ancrod (DB05099)

Also known as: Brain Infarction / Stroke NOS / Cerebral infarction / Cerebral infarct / Infarct cerebral

IndicationStatusPhase
DBCOND0125631 (Infarction, Brain)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00343174Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms